BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct acting antivirals
1
Generic vs brand forms of direct acting antivirals for hepatitis C virus treatment in Egyptian children
12/26/2025 10:27:29 AM | Browse: 108 | Download: 411
2
Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?
6/14/2024 8:01:41 AM | Browse: 144 | Download: 536
3
Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
5/22/2024 11:33:24 AM | Browse: 324 | Download: 913
4
Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C
12/25/2023 6:03:15 AM | Browse: 297 | Download: 1630
5
Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
10/25/2023 8:49:11 AM | Browse: 400 | Download: 1305
6
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
12/2/2022 12:50:19 PM | Browse: 629 | Download: 1950
7
Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
6/23/2022 2:39:01 PM | Browse: 768 | Download: 1898
8
Breakthroughs and challenges in the management of pediatric viral hepatitis
5/20/2021 8:38:05 AM | Browse: 843 | Download: 1943
9
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
10/12/2018 5:32:21 AM | Browse: 1744 | Download: 2196
10
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 1557 | Download: 2123
11
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
3/26/2018 8:48:04 AM | Browse: 1419 | Download: 2796
12
Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?
3/4/2018 12:36:47 PM | Browse: 1266 | Download: 2088
13
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 1520 | Download: 2993
14
Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
7/5/2017 4:40:08 AM | Browse: 1345 | Download: 2500
15
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
3/6/2017 3:54:00 PM | Browse: 1721 | Download: 2442
16
Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment
2/26/2017 6:20:00 PM | Browse: 1611 | Download: 2036
17
Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
11/4/2016 10:35:00 AM | Browse: 1523 | Download: 2899
18
Hepatitis C virus: A time for decisions. Who should be treated and when?
1/29/2016 11:06:00 AM | Browse: 1439 | Download: 2974
19
Treatment strategies for chronic hepatitis C prior to and following liver transplantation
1/7/2016 12:14:00 PM | Browse: 1377 | Download: 2142
20
Hepatitis C genotype 4: The past, present, and future
12/4/2015 3:24:00 PM | Browse: 2270 | Download: 3059
21
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?
10/30/2015 11:57:00 AM | Browse: 1841 | Download: 2475
22
Predictive factors associated with hepatitis C antiviral therapy response
6/29/2015 5:40:00 PM | Browse: 1433 | Download: 2513
23
Hepatitis C virus: Virology, diagnosis and treatment
6/3/2015 12:01:00 PM | Browse: 1878 | Download: 2557
24
Hepatitis C: New challenges in liver transplantation
5/20/2015 5:01:00 PM | Browse: 1420 | Download: 2887
25
Impact of all oral anti-hepatitis C virus therapy: A meta-analysis
4/19/2015 5:46:00 PM | Browse: 1383 | Download: 2262
26
Management of patients with hepatitis C infection and renal disease
2/13/2015 9:30:00 AM | Browse: 1746 | Download: 1746
27
Complementary and alternative medications in hepatitis C infection
9/10/2014 6:38:00 PM | Browse: 1312 | Download: 1303
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.